2.40
+0.055(+2.35%)
Currency In USD
| Previous Close | 2.34 |
| Open | 2.31 |
| Day High | 2.4 |
| Day Low | 2.31 |
| 52-Week High | 3.29 |
| 52-Week Low | 1.66 |
| Volume | 75,909 |
| Average Volume | 318,369 |
| Market Cap | 202.93M |
| PE | -8.87 |
| EPS | -0.27 |
| Moving Average 50 Days | 2.1 |
| Moving Average 200 Days | 2.14 |
| Change | 0.06 |
If you invested $1000 in Stereotaxis, Inc. (STXS) 10 years ago, it would be worth $1,663.19 as of December 26, 2024 at a share price of $2.395. Whereas If you bought $1000 worth of Stereotaxis, Inc. (STXS) shares 5 years ago, it would be worth $464.15 as of December 26, 2024 at a share price of $2.395.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
GlobeNewswire Inc.
Dec 09, 2024 12:25 PM GMT
ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced that the Magbot™ Magnetic Navigation Ablation Catheter has received regulato
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems
GlobeNewswire Inc.
Dec 02, 2024 1:45 PM GMT
ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical Systems”) today announced that Stereotaxis’ latest GenesisX robotic system is being featured for the fi
Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 26, 2024 1:28 PM GMT
ST. LOUIS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the